Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda C Johansson

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The FEBS Journal|November 7, 2019
Structural insights into melatonin receptorsBenjamin Stauch, Linda C Johansson, Vadim Cherezov
Trends in Biochemical Sciences|July 23, 2017
A Bright Future for Serial Femtosecond Crystallography with XFELsLinda C Johansson, Benjamin Stauch, Andrii Ishchenko, et al.
Current Opinion in Structural Biology|July 8, 2009
Membrane protein crystallization from lipidic phasesLinda C Johansson, Annemarie B Wöhri, Gergely Katona, et al.
Clinical Pharmacokinetics|May 13, 2003
No influence of ethnic origin on the pharmacokinetics and pharmacodynamics of melagatran following oral administration of ximelagatran, a novel oral direct thrombin inhibitor, to healthy male volunteersLinda C Johansson, Magnus Andersson, Gunnar Fager, et al.
Clinical Pharmacokinetics|March 22, 2003
Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitorLinda C Johansson, Lars Frison, Ulrika Logren, et al.
Biochemistry|September 12, 2009
Lipidic sponge phase crystal structure of a photosynthetic reaction center reveals lipids on the protein surfaceAnnemarie B Wöhri, Weixiao Y Wahlgren, Erik Malmerberg, et al.
European Journal of Clinical Pharmacology|May 14, 2003
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjectsUlf G Eriksson, Ulf Bredberg, Kristina Gislén, et al.
British Journal of Pharmacology|December 23, 2025
Profiling of HCAR1 signalling reveals Gα<sub>i/o</sub> and Gα<sub>s</sub> activation without β-arrestin recruitment and the discovery of an allosteric agonistSimon Lind, Shane C Wright, Emilia Gvozdenovic, et al.
Cell Communication and Signaling : CCS|February 19, 2026
Free fatty acid receptor 2 allosterism is defined by cellular contextSimon Lind, Ayaan Abdi Ali, Sarah Al Hamoud Al Asswad, et al.
Elife|March 3, 2020
Structure-based discovery of potent and selective melatonin receptor agonistsNilkanth Patel, Xi Ping Huang, Jessica M Grandner, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The FEBS Journal|November 7, 2019
Structural insights into melatonin receptorsBenjamin Stauch, Linda C Johansson, Vadim Cherezov
Trends in Biochemical Sciences|July 23, 2017
A Bright Future for Serial Femtosecond Crystallography with XFELsLinda C Johansson, Benjamin Stauch, Andrii Ishchenko, et al.
Current Opinion in Structural Biology|July 8, 2009
Membrane protein crystallization from lipidic phasesLinda C Johansson, Annemarie B Wöhri, Gergely Katona, et al.
Clinical Pharmacokinetics|May 13, 2003
No influence of ethnic origin on the pharmacokinetics and pharmacodynamics of melagatran following oral administration of ximelagatran, a novel oral direct thrombin inhibitor, to healthy male volunteersLinda C Johansson, Magnus Andersson, Gunnar Fager, et al.
Clinical Pharmacokinetics|March 22, 2003
Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitorLinda C Johansson, Lars Frison, Ulrika Logren, et al.
Biochemistry|September 12, 2009
Lipidic sponge phase crystal structure of a photosynthetic reaction center reveals lipids on the protein surfaceAnnemarie B Wöhri, Weixiao Y Wahlgren, Erik Malmerberg, et al.
European Journal of Clinical Pharmacology|May 14, 2003
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjectsUlf G Eriksson, Ulf Bredberg, Kristina Gislén, et al.
British Journal of Pharmacology|December 23, 2025
Profiling of HCAR1 signalling reveals Gα<sub>i/o</sub> and Gα<sub>s</sub> activation without β-arrestin recruitment and the discovery of an allosteric agonistSimon Lind, Shane C Wright, Emilia Gvozdenovic, et al.
Cell Communication and Signaling : CCS|February 19, 2026
Free fatty acid receptor 2 allosterism is defined by cellular contextSimon Lind, Ayaan Abdi Ali, Sarah Al Hamoud Al Asswad, et al.
Elife|March 3, 2020
Structure-based discovery of potent and selective melatonin receptor agonistsNilkanth Patel, Xi Ping Huang, Jessica M Grandner, et al.
Pageof 3